KNSA 分类 A Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 七月 28, 2026
$75.79
· % 处于52周区间
· 高于低点
· 至高点
$35.2052周低点
$82.9452周高点
市值 (MRQ)
$5.91B
P/E (TTM)
77.3
EPS (TTM)
$0.98
收入 (TTM)
$841M
KNSA 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$75.79
市值 (MRQ)
$5.91B
P/E (TTM)
77.3
EPS (TTM)
$0.98
收入 (TTM)
$841M
ROE (TTM)
14.0%
52周区间
$35–$83
KNSA 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
收入$678M2021-12-31 → 2025-12-31
EPS$0.752019-12-31 → 2025-12-31
自由现金流$136M2018-12-31 → 2025-12-31
净利率9.6%2021-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | KNSA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | 77.35年均值 ≈22.1 | ≈22.1 | · | · | |
| P/S (TTM) | 7.05年均值 ≈7.7 | ≈7.7 | · | · | |
| 市净率 (MRQ) | 9.05年均值 ≈3.7 | ≈3.7 | · | · | |
| 股价/自由现金流 (TTM) | 32.35年均值 ≈70.0 | ≈70.0 | · | · | |
| 市现率 (TTM) | 32.05年均值 ≈69.0 | ≈69.0 | · | · | |
| 市净率（有形资产） (MRQ) | 9.25年均值 ≈3.9 | ≈3.9 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | KNSA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | 11.9%5年均值 ≈-82.1% | ≈-82.1% | · | · | |
| EBITDA Margin (息税折旧摊销前利润率) | 11.4%5年均值 ≈-82.1% | ≈-82.1% | · | · | |
| 税前利润率 (TTM) | 13.6%5年均值 ≈-80.5% | ≈-80.5% | · | · | |
| 净利润率 (TTM) | 9.6%5年均值 ≈-64.5% | ≈-64.5% | · | · | |
| ROA (TTM) | 10.4%5年均值 ≈0.51% | ≈0.51% | · | · | |
| ROE (TTM) | 14.0%5年均值 ≈-5.5% | ≈-5.5% | · | · | |
| ROIC | 9.0%5年均值 ≈-8.6% | ≈-8.6% | · | · |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | KNSA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 3.95年均值 ≈4.2 | ≈4.2 | · | · | |
| 速动比率 (MRQ) | 3.25年均值 ≈3.6 | ≈3.6 | · | · |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | KNSA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | 60.1%5年均值 ≈152.7% | ≈152.7% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 45.5% | · | · | · | |
| EPS YoY | -92.3% | · | · | · | |
| Net Income YoY (净利润同比增长) | -92.3% | · | · | · | |
| EPS CAGR 3Y (每股收益年复合增长率（3年）) | -33.9% | · | · | · | |
| Net Income CAGR 3Y (净利润年复合增长率（3年）) | -31.5% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | KNSA | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 1.05年均值 ≈0.6 | ≈0.6 | · | · | |
| Inventory Turnover (库存周转率) | 1.95年均值 ≈3.0 | ≈3.0 | · | · | |
| Receivables Turnover (应收账款周转率) | 23.65年均值 ≈19.8 | ≈19.8 | · | · | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$1.9M | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
20.8%
下次报告
十月 26, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 七月 27, 2026 | $0.30 | $0.30 | -1.5% |
| 2026年3月31日 | $0.27 | $0.21 | 31.5% | |
| 2025年12月31日 | $0.17 | $0.38 | -55.5% | |
| 2025年9月30日 | $0.23 | $0.33 | -30.3% | |
| 2025年6月30日 | $0.23 | $0.19 | 23.8% | |
| 2025年3月31日 | $0.11 | $0.04 | 157.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue | $678M | $423M | $270M | $220M | $39M | |
| Cost of Revenue | $78M | $61M | $33M | $23M | $9M | |
| R&D Expense | $97M | $112M | $76M | $65M | $99M | |
| SG&A Expense | $196M | $168M | $129M | $98M | $86M | |
| Operating Income | $77M | $-46M | $-25M | $10M | $-157M | |
| Interest Income | $12M | $9M | $8M | $1M | $97.0K | |
| Pretax Income | $89M | $-36M | $-17M | $11M | $-157M | |
| Income Tax | $30M | $7M | $-31M | $-172M | $1M | |
| Net Income | $59M | $-43M | $14M | $183M | $-158M | |
| EPS (Basic) | $0.80 | $-0.60 | $0.20 | $2.64 | $-2.30 | |
| EPS (Diluted) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 | |
| Shares (Basic) | 74,200,924 | 71,424,159 | 70,058,952 | 69,382,275 | 68,576,810 | |
| Shares (Diluted) | 78,979,030 | 71,424,159 | 71,922,915 | 70,421,322 | 68,576,810 | |
| EBITDA | $77M | $-46M | $-25M | $10M | $-157M |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $166M | $184M | $108M | $123M | $122M | |
| Short-term Investments | $248M | $60M | $98M | $68M | $60M | |
| Receivables | $16M | $42M | $21M | $13M | $4M | |
| Inventory | $55M | $26M | $31M | $22M | $4M | |
| Prepaid Expense | $43M | $20M | $18M | $11M | $7M | |
| Current Assets | $527M | $332M | $276M | $243M | $196M | |
| PP&E (Net) | $2M | $662.0K | $734.0K | $2M | $3M | |
| PP&E (Gross) | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $7M | $8M | $8M | $7M | $6M | |
| Intangibles | $15M | $16M | $17M | $18M | $19M | |
| Other Non-current Assets | $11M | $10M | $827.0K | $6M | $9M | |
| Total Assets | $764M | $581M | $526M | $460M | $233M | |
| Accounts Payable | $2M | $2M | $8M | $8M | $2M | |
| Accrued Liabilities | $42M | $32M | $28M | $30M | $38M | |
| Current Liabilities | $139M | $101M | $64M | $47M | $45M | |
| Capital Leases | $7M | $8M | $10M | $3M | $3M | |
| Other Non-current Liabilities | $19M | $2M | $2M | $2M | $270.0K | |
| Total Liabilities | $196M | $142M | $87M | $64M | $48M | |
| Paid-in Capital | $1.03B | $960M | $917M | $888M | $860M | |
| Retained Earnings | $-462M | $-521M | $-478M | $-492M | $-675M | |
| AOCI | $-25.0K | $-163.0K | $6.0K | $44.0K | $-66.0K | |
| Stockholders' Equity | $568M | $438M | $439M | $396M | $185M | |
| Liabilities + Equity | $764M | $581M | $526M | $460M | $233M | |
| Shares Outstanding | 76,294,164 | 72,516,059 | 70,460,617 | 69,697,503 | 69,060,403 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | |
| Stock-based Comp | $37M | $31M | $27M | $25M | $25M | |
| Deferred Tax | $13M | $8M | $-34M | $-185M | $11.0K | |
| Operating Cash Flow | $138M | $26M | $13M | $6M | $-126M | |
| CapEx | $2M | $277.0K | $130.0K | $105.0K | $415.0K | |
| Investing Cash Flow | $-189M | $38M | $-30M | $-8M | $129M | |
| Financing Cash Flow | $33M | $12M | $1M | $3M | $6M | |
| Taxes Paid | $3M | $2M | $6M | $11M | $1M | |
| Free Cash Flow | $136M | $25M | $13M | $6M | $-127M |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Operating Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | |
| Net Margin | 8.7% | -10.2% | 5.2% | 83.3% | -409.7% | |
| Pretax Margin | 13.1% | -8.5% | -6.2% | 5.0% | -406.1% | |
| EBITDA Margin | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% | |
| ROA | 8.8% | -7.8% | 2.9% | 53.0% | -54.2% | |
| ROE | 11.1% | -9.9% | 3.3% | 47.0% | -79.1% | |
| ROIC | 9.0% | -12.4% | 4.9% | 41.0% | -85.4% |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 3.3 | 4.3 | 5.2 | 4.4 | |
| Quick Ratio | 3.1 | 2.8 | 3.6 | 4.3 | 4.2 |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.8 | 0.5 | 0.6 | 0.1 | |
| Inventory Turnover | 1.9 | 2.1 | · | · | 5.0 | |
| Receivables Turnover | 23.6 | 13.4 | 15.9 | 26.5 | 19.3 |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $7.44 | $6.05 | $6.23 | $5.68 | $2.68 | |
| Revenue / Share | $8.58 | $5.93 | $3.76 | $3.13 | $0.56 | |
| Cash Flow / Share | $1.75 | $0.36 | $0.18 | $0.08 | $-1.84 | |
| Cash / Share | $2.17 | $2.53 | $1.53 | $1.76 | $1.77 | |
| EPS (TTM) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue YoY | 60.1% | 56.6% | 22.7% | 471.2% | · | |
| Revenue CAGR 3Y | 45.5% | 122.3% | · | · | · | |
| EPS YoY | · | · | -92.3% | · | · | |
| EPS CAGR 3Y | -33.9% | · | · | · | · | |
| Net Income YoY | · | · | -92.3% | · | · | |
| Net Income CAGR 3Y | -31.5% | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Revenue TTM | $678M | $423M | $270M | $220M | $39M | |
| Net Income TTM | $59M | $-43M | $14M | $183M | $-158M | |
| Market Cap | $3.15B | $1.43B | $1.24B | $1.04B | $813M | |
| P/E | 55.0 | -33.0 | 87.7 | 5.8 | -5.1 | |
| P/S | 4.6 | 3.4 | 4.6 | 4.7 | 21.1 | |
| P/B | 5.5 | 3.3 | 2.8 | 2.6 | 4.4 | |
| P / Tangible Book | 5.7 | 3.4 | 2.9 | 2.8 | 4.9 | |
| P / Cash Flow | 22.8 | 55.8 | 92.9 | 179.8 | -6.4 | |
| P / FCF | 23.1 | 56.4 | 93.8 | 183.1 | -6.4 | |
| Earnings Yield | 1.8% | -3.0% | 1.1% | 17.4% | -19.5% |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $214M | $202M | $181M | $157M | $138M | $123M | $112M | $109M | $80M | $83M | $67M | $71M | $48M | $62M | $99M | |
| Cost of Revenue | $24M | $21M | $21M | $20M | $19M | $18M | $18M | $20M | $12M | $11M | $10M | $9M | $8M | $7M | $7M | $7M | |
| R&D Expense | $41M | $27M | $35M | $24M | $19M | $19M | $35M | $26M | $24M | $26M | $20M | $17M | $24M | $15M | $14M | $16M | |
| SG&A Expense | $64M | $61M | $57M | $49M | $47M | $44M | $41M | $46M | $42M | $39M | $37M | $34M | $29M | $29M | $27M | $25M | |
| Operating Income | $27M | $29M | $20M | $24M | $20M | $13M | $-19M | $-10M | $-117.0K | $-17M | $81.0K | $-11M | $-3M | $-11M | $6M | $46M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $771.0K | $322.0K | |
| Pretax Income | $31M | $33M | $23M | $27M | $23M | $16M | $-17M | $-7M | $2M | $-14M | $2M | $-8M | $-1M | $-9M | $7M | $47M | |
| Income Tax | $6M | $10M | $9M | $9M | $5M | $7M | $-8M | $5M | $6M | $3M | $-23M | $5M | $-16M | $3M | $2M | $-177M | |
| Net Income | $25M | $23M | $14M | $18M | $18M | $9M | $-9M | $-13M | $-4M | $-18M | $25M | $-14M | $15M | $-12M | $4M | $224M | |
| EPS (Basic) | $0.33 | $0.30 | $0.19 | $0.25 | $0.24 | $0.12 | $-0.11 | $-0.18 | $-0.06 | $-0.25 | $0.37 | $-0.20 | $0.21 | $-0.18 | $0.06 | $3.23 | |
| EPS (Diluted) | $0.30 | $0.27 | $0.18 | $0.23 | $0.23 | $0.11 | $-0.11 | $-0.18 | $-0.06 | $-0.25 | $0.37 | $-0.20 | $0.21 | $-0.18 | $0.07 | $3.18 | |
| Shares (Basic) | 77,577,675 | 76,516,535 | · | 74,714,846 | 73,438,530 | 72,647,121 | · | 71,726,685 | 71,004,640 | 70,633,023 | · | 70,186,016 | 69,918,287 | 69,751,697 | · | 69,445,071 | |
| Shares (Diluted) | 83,398,051 | 82,409,703 | · | 80,035,400 | 77,942,082 | 76,145,617 | · | 71,726,685 | 71,004,640 | 70,633,023 | · | 70,186,016 | 71,634,729 | 69,751,697 | · | 70,552,018 | |
| EBITDA | $27M | $29M | · | $24M | $20M | $13M | · | $-10M | $-117.0K | $-17M | · | $-11M | $-3M | $-11M | · | $46M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $176M | $190M | $166M | $175M | $192M | $157M | $184M | $97M | $99M | $141M | · | $118M | $113M | $81M | · | $176M | |
| Short-term Investments | $350M | $278M | $248M | $177M | $116M | $111M | $60M | $126M | $119M | $72M | · | $83M | $72M | $107M | · | $25M | |
| Receivables | $23M | $23M | $16M | $52M | $32M | $40M | $42M | $25M | $20M | $16M | · | $3M | $25M | $7M | · | $11M | |
| Inventory | $71M | $73M | $55M | $41M | $48M | $22M | $26M | $29M | $35M | $27M | · | $26M | $24M | $23M | · | $15M | |
| Prepaid Expense | $48M | $30M | $43M | $30M | $32M | $25M | $20M | $34M | $27M | $14M | · | $26M | $12M | $13M | · | $15M | |
| Current Assets | $669M | $594M | $527M | $476M | $420M | $356M | $332M | $311M | $301M | $271M | · | $256M | $246M | $232M | · | $242M | |
| PP&E (Net) | $3M | $2M | $2M | $2M | $1M | $606.0K | $662.0K | $561.0K | $625.0K | $712.0K | · | $918.0K | $1M | $1M | · | $2M | |
| PP&E (Gross) | $10M | $9M | $9M | $9M | $9M | $8M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $8M | $7M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $7M | $7M | · | $7M | |
| Intangibles | $15M | $15M | $15M | $16M | $16M | $16M | $16M | $16M | $17M | $17M | · | $18M | $18M | $18M | · | $18M | |
| Other Non-current Assets | $11M | $11M | $11M | $8M | $8M | $8M | $10M | $8M | $8M | $4M | · | $2M | $2M | $2M | · | $6M | |
| Total Assets | $896M | $825M | $764M | $712M | $661M | $599M | $581M | $555M | $542M | $520M | · | $483M | $484M | $443M | · | $460M | |
| Accounts Payable | $12M | $24M | $2M | $6M | $9M | $2M | $2M | $8M | $7M | $6M | · | $1M | $648.0K | $1M | · | $1M | |
| Accrued Liabilities | $47M | $33M | $42M | $31M | $36M | $22M | $32M | $40M | $33M | $45M | · | $41M | $35M | $21M | · | $31M | |
| Current Liabilities | $171M | $157M | $139M | $124M | $118M | $97M | $101M | $96M | $84M | $64M | · | $53M | $47M | $37M | · | $56M | |
| Capital Leases | $5M | $6M | $7M | $7M | $7M | $8M | $8M | $9M | $9M | $10M | · | $11M | $11M | $2M | · | $3M | |
| Other Non-current Liabilities | $34M | $25M | $19M | $15M | $9M | $5M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $242M | $220M | $196M | $177M | $166M | $142M | $142M | $118M | $107M | $88M | · | $78M | $73M | $53M | · | $76M | |
| Paid-in Capital | $1.07B | $1.05B | $1.03B | $1.01B | $990M | $970M | $960M | $949M | $935M | $928M | · | $908M | $901M | $894M | · | $881M | |
| Retained Earnings | $-414M | $-440M | $-462M | $-476M | $-495M | $-513M | $-521M | $-512M | $-500M | $-496M | · | $-503M | $-489M | $-504M | · | $-496M | |
| AOCI | $-1M | $-665.0K | $-25.0K | $-155.0K | $-53.0K | $-165.0K | $-163.0K | $-41.0K | $-130.0K | $-53.0K | · | $-1.0K | $13.0K | $55.0K | · | $-70.0K | |
| Stockholders' Equity | $654M | $606M | $568M | $535M | $495M | $457M | $438M | $437M | $435M | $432M | $439M | $405M | $412M | $390M | $396M | $384M | |
| Liabilities + Equity | $896M | $825M | $764M | $712M | $661M | $599M | $581M | $555M | $542M | $520M | · | $483M | $484M | $443M | · | $460M | |
| Shares Outstanding | 77,979,674 | 76,689,460 | 76,294,164 | 75,424,653 | 74,032,363 | 72,797,332 | 72,516,059 | 72,158,189 | 71,082,278 | 70,819,096 | 70,460,617 | 70,316,631 | 70,002,663 | 69,833,079 | 69,697,503 | 69,524,338 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $472.0K | $468.0K | $467.0K | $384.0K | $358.0K | $345.0K | $400.0K | $399.0K | $430.0K | $466.0K | $540.0K | $603.0K | $602.0K | $596.0K | $602.0K | $493.0K | |
| Stock-based Comp | $12M | $10M | $10M | $10M | $9M | $8M | $8M | $8M | $7M | $7M | $8M | $7M | $6M | $6M | $6M | $6M | |
| Deferred Tax | $3M | $5M | $3M | $4M | $3M | $3M | $-3M | $-4M | $11M | $4M | $-26M | $10M | $-19M | $1M | $348.0K | · | |
| Amort. of Intangibles | $250.0K | $250.0K | · | $250.0K | $250.0K | $250.0K | · | $250.0K | $250.0K | · | · | · | · | · | · | · | |
| Operating Cash Flow | $47M | $50M | $54M | $34M | $28M | $22M | $19M | $-2M | $5M | $4M | $4M | $17M | $-4M | $-4M | $-12M | $62M | |
| CapEx | $663.0K | $161.0K | $633.0K | $671.0K | $165.0K | $99.0K | $193.0K | $0 | $0 | $84.0K | $56.0K | $16.0K | $34.0K | $24.0K | $-32.0K | $22.0K | |
| Investing Cash Flow | $-74M | $-32M | $-71M | $-63M | $-4M | $-52M | $65M | $-6M | $-47M | $26M | $-15M | $-12M | $36M | $-38M | $-43M | $19M | |
| Financing Cash Flow | $12M | $6M | $8M | $12M | $11M | $3M | $2M | $7M | $-178.0K | $4M | $695.0K | $552.0K | $158.0K | $90.0K | $1M | $361.0K | |
| Taxes Paid | · | · | $3.0K | $0 | $1.0K | $3M | $1M | $-769.0K | · | · | $-1M | $201.0K | $4M | $3M | $6M | $1M | |
| Free Cash Flow | · | $50M | · | · | · | $22M | · | · | · | $4M | · | · | · | $-4M | · | · |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.2% | 13.7% | · | 13.3% | 12.9% | 9.6% | · | -8.6% | -0.11% | -20.7% | · | -16.3% | -4.4% | -23.2% | · | 46.8% | |
| Net Margin | 10.4% | 10.5% | · | 10.2% | 11.4% | 6.2% | · | -11.3% | -3.6% | -22.2% | · | -20.7% | 20.9% | -25.4% | · | 226.0% | |
| Pretax Margin | 12.8% | 15.2% | · | 15.0% | 14.6% | 11.3% | · | -6.4% | 2.1% | -17.9% | · | -12.7% | -1.7% | -19.4% | · | 47.1% | |
| EBITDA Margin | 11.2% | 13.7% | · | 13.3% | 12.9% | 9.6% | · | -8.6% | -0.11% | -20.7% | · | -16.3% | -4.4% | -23.2% | · | 46.8% | |
| ROA | 3.3% | 3.2% | · | 2.9% | 3.0% | 1.5% | · | -2.4% | -0.76% | -3.7% | · | -2.9% | 4.3% | -3.6% | · | 62.9% | |
| ROE | 4.4% | 4.2% | · | 3.8% | 3.8% | 1.9% | · | -3.0% | -0.92% | -4.3% | · | -3.5% | 5.3% | -4.4% | · | 74.9% | |
| ROIC | 3.4% | 3.3% | · | 3.0% | 3.2% | 1.6% | · | -3.9% | 0.05% | -4.8% | · | -4.4% | 9.3% | -3.8% | · | 58.0% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 3.8 | · | 3.8 | 3.6 | 3.7 | · | 3.2 | 3.6 | 4.2 | · | 4.8 | 5.2 | 6.3 | · | 4.3 | |
| Quick Ratio | 3.2 | 3.1 | · | 3.3 | 2.9 | 3.2 | · | 2.6 | 2.8 | 3.6 | · | 3.8 | 4.4 | 5.3 | · | 3.8 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.1 | · | 0.3 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.6 | 0.4 | 0.7 | · | 0.7 | 0.4 | 0.4 | · | 0.5 | 0.4 | · | · | · | |
| Receivables Turnover | 8.8 | 6.8 | · | 4.7 | 6.0 | 4.9 | · | 8.0 | 4.8 | 6.8 | · | 9.4 | 4.4 | 2.6 | · | 13.8 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.39 | $7.90 | · | $7.10 | $6.69 | $6.28 | · | $6.06 | $6.12 | $6.10 | · | $5.76 | $5.88 | $5.59 | · | $5.52 | |
| Revenue / Share | $2.92 | $2.60 | · | $2.26 | $2.01 | $1.81 | · | $1.56 | $1.53 | $1.13 | · | $0.96 | $1.00 | $0.69 | · | $1.41 | |
| Cash Flow / Share | · | $0.61 | · | · | · | $0.29 | · | · | · | $0.06 | · | · | · | $-0.06 | · | · | |
| Cash / Share | $2.25 | $2.48 | · | $2.32 | $2.59 | $2.16 | · | $1.35 | $1.40 | $1.99 | · | $1.68 | $1.61 | $1.15 | · | $2.53 | |
| EPS (TTM) | $0.98 | $0.91 | · | $0.46 | $0.05 | $-0.24 | · | $-0.12 | $-0.14 | $0.13 | · | $-0.10 | $3.28 | $2.78 | · | $2.00 |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $841M | $754M | · | $598M | $529M | $481M | · | $384M | $339M | $302M | · | $249M | $281M | $236M | · | $177M | |
| Net Income TTM | $81M | $73M | · | $36M | $5M | $-17M | · | $-9M | $-10M | $9M | · | $-7M | $231M | $196M | · | $143M | |
| Market Cap | $4.99B | $3.69B | · | $2.93B | $2.05B | $1.62B | · | $1.80B | $1.33B | $1.40B | · | $1.22B | $986M | $751M | · | $893M | |
| P/E | 65.3 | 52.9 | · | 84.4 | 553.4 | -92.5 | · | -208.2 | -133.4 | 151.8 | · | -173.7 | 4.3 | 3.9 | · | 6.4 | |
| P/S | 5.9 | 4.9 | · | 4.9 | 3.9 | 3.4 | · | 4.7 | 3.9 | 4.6 | · | 4.9 | 3.5 | 3.2 | · | 5.0 | |
| P/B | 7.6 | 6.1 | · | 5.5 | 4.1 | 3.5 | · | 4.1 | 3.1 | 3.2 | · | 3.0 | 2.4 | 1.9 | · | 2.3 | |
| P / Tangible Book | 7.8 | 6.3 | · | 5.6 | 4.3 | 3.7 | · | 4.3 | 3.2 | 3.4 | · | 3.2 | 2.5 | 2.0 | · | 2.4 | |
| P / Cash Flow | · | 73.6 | · | · | · | 72.4 | · | · | · | 350.5 | · | · | · | -176.1 | · | · | |
| Earnings Yield | 1.5% | 1.9% | · | 1.2% | 0.18% | -1.1% | · | -0.48% | -0.75% | 0.66% | · | -0.58% | 23.3% | 25.8% | · | 15.6% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 收入 | $678M | $423M | $270M | $220M | $39M |
| 营业利润率 % | 11.4% | -10.8% | -9.3% | 4.4% | -406.4% |
| 净收入 | $59M | $-43M | $14M | $183M | $-158M |
| 稀释后每股收益 (EPS) | $0.75 | $-0.60 | $0.20 | $2.60 | $-2.30 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 3.8 | 3.3 | 4.3 | 5.2 | 4.4 |
| 速动比率 | 3.1 | 2.8 | 3.6 | 4.3 | 4.2 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $136M | $25M | $13M | $6M | $-127M |
机构持有人 (13F) 280 家申报者 · $3.1B 总计 · 截至 2026年9月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
280
持有价值
$3.1B
新仓位
69
已退出持仓
26
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 69 (+25 与上一季度对比) | 26 (-7 与上一季度对比) | 89 (+16 与上一季度对比) | 77 (-8 与上一季度对比) | +321K |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| FMR LLC | $445818527 | 6971361 | 14.50% | 股份 |
| Rubric Capital Management LP | $255787210 | 3999800 | 8.32% | 股份 |
| BAKER BROS. ADVISORS LP | $181275420 | 2834643 | 5.90% | 股份 |
| BlackRock, Inc. | $175198378 | 2739615 | 5.70% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $144519902 | 2259889 | 4.70% | 股份 |
| VANGUARD GROUP INC | $128408651 | 3112937 | 4.18% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $122229873 | 1911335 | 3.98% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $87025718 | 1360840 | 2.83% | 股份 |
| MORGAN STANLEY | $64662626 | 1011143 | 2.10% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $61233020 | 957514 | 1.99% | 股份 |
| Spruce Street Capital LP | $58710577 | 918070 | 1.91% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $55937333 | 874786 | 1.82% | 股份 |
| Invesco Ltd. | $49420945 | 772806 | 1.61% | 股份 |
| Driehaus Capital Management LLC | $45928826 | 718199 | 1.49% | 股份 |
| STATE STREET CORP | $45033206 | 704194 | 1.46% | 股份 |
| Point72 Asset Management, L.P. | $42174577 | 659493 | 1.37% | 股份 |
| RICE HALL JAMES & ASSOCIATES, LLC | $39964146 | 624928 | 1.30% | 股份 |
| Pictet Asset Management Holding SA | $38923168 | 608650 | 1.27% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $38633635 | 604180 | 1.26% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $36617642 | 572598 | 1.19% | 股份 |
| D. E. Shaw & Co., Inc. | $36435896 | 569756 | 1.19% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $35906646 | 561480 | 1.17% | 股份 |
| VICTORY CAPITAL MANAGEMENT INC | $30711668 | 480245 | 1.00% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $27958428 | 437192 | 0.91% | 股份 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $27583170 | 431324 | 0.90% | 股份 |
| ORBIMED ADVISORS LLC | $26897370 | 420600 | 0.87% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $26778671 | 556151 | 0.87% | 股份 |
| BANK OF AMERICA CORP /DE/ | $26437633 | 413411 | 0.86% | 股份 |
| OBERWEIS ASSET MANAGEMENT INC/ | $26413524 | 413034 | 0.86% | 股份 |
| Aberdeen Group plc | $25802866 | 403485 | 0.84% | 股份 |
| Fisher Asset Management, LLC | $25469110 | 398266 | 0.83% | 股份 |
| DEUTSCHE BANK AG\ | $24787404 | 387606 | 0.81% | 股份 |
| AQR CAPITAL MANAGEMENT LLC | $23983744 | 375039 | 0.78% | 股份 |
| Penn Capital Management Company, LLC | $23565426 | 368114 | 0.77% | 股份 |
| JANUS HENDERSON GROUP PLC | $23197334 | 481023 | 0.75% | 股份 |
| NORTHERN TRUST CORP | $20159981 | 315246 | 0.66% | 股份 |
| Balyasny Asset Management L.P. | $19804164 | 309682 | 0.64% | 股份 |
| Qube Research & Technologies Ltd | $19445916 | 304080 | 0.63% | 股份 |
| Caption Management, LLC | $19172210 | 299800 | 0.62% | 卖出期权 |
| NEW YORK STATE COMMON RETIREMENT FUND | $17431427 | 272579 | 0.57% | 股份 |
| NOMURA HOLDINGS INC | $17312800 | 270724 | 0.56% | 股份 |
| Soleus Capital Management, L.P. | $15754274 | 246353 | 0.51% | 股份 |
| ESSEX INVESTMENT MANAGEMENT CO LLC | $15436379 | 241382 | 0.50% | 股份 |
| Bank of New York Mellon Corp | $14870367 | 232531 | 0.48% | 股份 |
| Cubist Systematic Strategies, LLC | $14806633 | 381319 | 0.48% | 股份 |
| ArrowMark Colorado Holdings LLC | $13784167 | 215546 | 0.45% | 股份 |
| STEMPOINT CAPITAL LP | $13380514 | 209234 | 0.44% | 股份 |
| GOLDMAN SACHS GROUP INC | $12237727 | 191364 | 0.40% | 股份 |
| SEI INVESTMENTS CO | $12058768 | 188565 | 0.39% | 股份 |
| BRAIDWELL LP | $11755417 | 183822 | 0.38% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker, FBB3 LLC ×7 申报 | 2026年5月26日 | 7.00% | 修订 | 被动投资 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 19 位内幕人士 · 12 位高管 · 7 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Sanj K Patel | CHAIRMAN & CEO | 2026年9月1日 M | 92348 | 0 | 12 | $-39426213 |
| Mark Ragosa | CHIEF FINANCIAL OFFICER | 2026年9月1日 M | 20854 | 0 | 8 | $-5557371 |
| Chris Heberlig | EVP & CFO | 2019年9月17日 A | 42991 | 0 | 0 | $0 |
| Stephen F. Mahoney | President & COO | 2019年9月17日 A | 79589 | 0 | 0 | $0 |
| Ross Moat | CHIEF OPERATING OFFICER | 2026年9月1日 M | 16307 | 0 | 2 | $-194502 |
| John Paolini | CHIEF MEDICAL OFFICER | 2026年9月1日 M | 69922 | 0 | 6 | $-7996373 |
| Michael R Megna | CHIEF ACCOUNTING OFFICER | 2026年9月1日 M | 29062 | 0 | 4 | $-2641483 |
| Dhiraj H Malkani | CHIEF STRATEGY OFFICER | 2026年7月1日 A | · | 0 | 0 | $0 |
| Eben Tessari | CHIEF STRATEGY OFFICER | 2026年4月7日 M | 23130 | 0 | 6 | $-1489360 |
| Arian Pano | Chief Clinical Dev. Officer | 2021年9月2日 A | · | 0 | 0 | $0 |
| Thomas W. Beetham | EVP & Chief Legal Officer | 2021年3月20日 A | 297523 | 0 | 0 | $0 |
| Qasim Rizvi | Chief Commercial Officer | 2020年12月31日 M | 5176 | 0 | 0 | $0 |
| Barry D Quart | 董事 | 2026年8月19日 G | 12745 | 0 | 8 | $-2684500 |
| Richard S Levy | 董事 | 2026年8月1日 M | 22359 | 0 | 0 | $0 |
| Bradley G Cole | 董事 | 2026年7月29日 G | 7172 | 0 | 1 | $-299092 |
| Tracey L Mccain | 董事 | 2026年5月29日 M | 15345 | 0 | 0 | $0 |
| Thomas Malley | 董事 | 2026年5月29日 M | 15345 | 0 | 0 | $0 |
| Kimberly J Popovits | 董事 | 2026年5月29日 M | 15345 | 0 | 0 | $0 |
| Carsten Boess | 10% 所有者 | 2018年5月29日 C | 79589 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 25 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IBBQ · Invesco Exchange-Traded Fund Trus... | 0.24% | 3411 SH | 2026年10月1日 | 每日 |
| IWO · iShares Trust | 0.21% | 399537 SH | 2026年9月11日 | 每日 |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.16% | 45447 SH | 2026年8月19日 | 每日 |
| OMFS · Invesco Exchange-Traded Self-Inde... | 0.11% | 3771 SH | 2026年10月1日 | 每日 |
| IWM · iShares Trust | 0.11% | 1082567 SH | 2026年9月11日 | 每日 |
| RSSL · Global X Funds | 0.10% | 20296 NS | 2026年7月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.08% | 244007 SH | 2026年8月19日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.07% | 149712 NS | 2026年7月31日 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.07% | 551977 SH | 2026年8月19日 | 每日 |
| ISCG · iShares Trust | 0.07% | 8664 SH | 2026年9月11日 | 每日 |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.04% | 14348 SH | 2026年10月1日 | 每日 |
| VB · VANGUARD INDEX FUNDS | 0.03% | 955916 SH | 2026年8月19日 | 每日 |
| VHT · VANGUARD WORLD FUND | 0.03% | 110484 SH | 2026年8月19日 | 每日 |
| WSML · iShares Trust | 0.02% | 2097 SH | 2026年9月11日 | 每日 |
| DFAC · Dimensional ETF Trust | 0.01% | 88365 NS | 2026年7月31日 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.01% | 3131 NS | 2026年7月31日 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.01% | 1652 NS | 2026年7月31日 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.01% | 8599 NS | 2026年7月31日 | N-PORT |
| IWV · iShares Trust | 0.00% | 11356 SH | 2026年9月11日 | 每日 |
| DFUS · Dimensional ETF Trust | 0.00% | 11390 NS | 2026年7月31日 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 1318886 SH | 2026年8月19日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 3504 SH | 2026年8月19日 | 每日 |
| ISCB · iShares Trust | · | 1878 SH | 2026年9月11日 | 每日 |
| ISCV · iShares Trust | · | 3056 SH | 2026年9月11日 | 每日 |
| SMMV · iShares Trust | · | 15367 SH | 2026年9月1日 | 每日 |
KNSA 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$98.50
+30.0%
5 35.7%
强烈买入
8 57.1%
买入
1 7.1%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
8 位分析师 · 2026-09-29平均目标 $98.00 +29.3%
← 低于所有目标
当前价格 $75.79
最低$87.00
平均值$98.00
最高$108.00
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 七月 28, 2026 申报